secwatch.observer — SEC 8-K summary
======================================

Issuer:     AdaptHealth Corp. (AHCO)
CIK:        0001725255
Form:       8-K
Filed at:   2022-11-08T23:59:59+00:00
Accession:  0001104659-22-115692
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AdaptHealth Q3 revenue $756.5M (+15.8% YoY); net income drops 72% to $16.1M; FY guidance narrowed
--------------------------------------------------------------------------------

- Q3 2022 net revenue $756.5M vs $653.3M in Q3 2021, +15.8%.
- Net income $16.1M ($0.11 diluted EPS) vs $58.1M ($0.20) in Q3 2021.
- Adjusted EBITDA $160.2M, +2.5% YoY; cash from ops $107.0M vs $27.1M.
- FY2022 guidance updated: revenue $2.950B-$3.010B; adjusted EBITDA $620M-$650M.
- Repurchased $10.6M of common stock during quarter under existing authorization.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725255/000110465922115692/0001104659-22-115692-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725255/000110465922115692/tm2229847d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-115692

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer